Agilent Technologies (NYSE:A) Issues Q4 2026 Earnings Guidance

Agilent Technologies (NYSE:A) updated its fourth quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.710-1.740 for the period, compared to the consensus estimate of 1.710. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion. Agilent Technologies also updated its FY 2026 guidance to 6.180-6.210 EPS.

Analyst Upgrades and Downgrades

Several research analysts recently commented on A shares. Jefferies Financial Group assumed coverage on Agilent Technologies in a research report on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price for the company. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Sanford C. Bernstein assumed coverage on shares of Agilent Technologies in a report on Friday, June 26th. They set an “outperform” rating and a $155.00 price objective for the company. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their target price for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. Finally, HSBC lowered their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Price Performance

Shares of A stock opened at $155.16 on Thursday. The stock’s fifty day moving average is $139.16 and its 200-day moving average is $126.65. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The stock has a market capitalization of $43.82 billion, a PE ratio of 31.16, a PEG ratio of 2.73 and a beta of 1.25. Agilent Technologies has a 52 week low of $108.35 and a 52 week high of $160.51.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. During the same period in the previous year, the business posted $1.37 earnings per share. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts expect that Agilent Technologies will post 6.05 EPS for the current fiscal year.

Key Headlines Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the approximately $1.84 billion analyst estimate. Adjusted earnings were $1.62 per share, above the $1.48-$1.49 consensus and up from $1.37 a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Management raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the $6.06 consensus, and set revenue guidance at approximately $7.5 billion, slightly ahead of expectations. Fourth-quarter EPS guidance of $1.71-$1.74 was at or above consensus. Agilent Boosts FY View on Higher 3Q Profit, Revenue
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit rose 23.3% to $444 million, while operating cash flow increased 43.4% to $519 million. The company ended the quarter with approximately $1.8 billion in cash and relatively moderate leverage. Agilent Technologies Stock Rises on Q3 2026 Earnings
• Neutral Sentiment: The earnings beat and guidance increase helped push the stock toward a recent high. However, Agilent already trades near its 52-week high, with a P/E ratio above 31 and a median analyst price target of about $155, suggesting much of the improved outlook may already be reflected in the valuation.

Institutional Trading of Agilent Technologies

Several hedge funds have recently modified their holdings of A. Fiduciary Trust Co raised its stake in Agilent Technologies by 1.6% during the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after purchasing an additional 77 shares in the last quarter. IHT Wealth Management LLC grew its stake in shares of Agilent Technologies by 4.9% in the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock worth $278,000 after buying an additional 96 shares in the last quarter. UMB Bank n.a. grew its stake in shares of Agilent Technologies by 3.0% in the 4th quarter. UMB Bank n.a. now owns 4,500 shares of the medical research company’s stock worth $612,000 after buying an additional 131 shares in the last quarter. Zions Bancorporation National Association UT increased its holdings in shares of Agilent Technologies by 17.2% in the 4th quarter. Zions Bancorporation National Association UT now owns 990 shares of the medical research company’s stock worth $135,000 after buying an additional 145 shares during the last quarter. Finally, Modern Wealth Management LLC increased its holdings in shares of Agilent Technologies by 5.7% in the 2nd quarter. Modern Wealth Management LLC now owns 2,889 shares of the medical research company’s stock worth $341,000 after buying an additional 157 shares during the last quarter.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.